KEGG   DISEASE: 3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency
Entry
H01079                      Disease                                
Name
3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency;
PHGDH Deficiency
Description
3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency is a rare autosomal recessive disorder caused by a defect in the synthesis of the amino acid L-serine characterized clinically by congenital microcephaly, psychomotor retardation, and infantile onset of intractable seizures. The biochemical abnormalities associated with this disorder are low concentrations of L-serine, D-serine, and glycine in cerebrospinal fluid (CSF) and plasma. Mutations have been identified in PHGDH, the gene encoding 3-PGDH.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Metabolic disorders
   Inborn errors of metabolism
    5C50  Inborn errors of amino acid or other organic acid metabolism
     H01079  3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency
Pathway-based classification of diseases [BR:br08402]
 Amino acid metabolism
  nt06033  Glycine, serine and arginine metabolism
   H01079  3-Phosphoglycerate dehydrogenase (3-PGDH) deficiency
Pathway
hsa01230  Biosynthesis of amino acids
hsa00260  Glycine, serine and threonine metabolism
Network
nt06033 Glycine, serine and arginine metabolism
Gene
PHGDH [HSA:26227] [KO:K00058]
Other DBs
ICD-11: 5C50.6
MeSH: C566618
OMIM: 601815
Reference
  Authors
Tabatabaie L, Klomp LW, Rubio-Gozalbo ME, Spaapen LJ, Haagen AA, Dorland L, de Koning TJ
  Title
Expanding the clinical spectrum of 3-phosphoglycerate dehydrogenase deficiency.
  Journal
J Inherit Metab Dis 34:181-4 (2011)
DOI:10.1007/s10545-010-9249-5
Reference
  Authors
Tabatabaie L, de Koning TJ, Geboers AJ, van den Berg IE, Berger R, Klomp LW
  Title
Novel mutations in 3-phosphoglycerate dehydrogenase (PHGDH) are distributed throughout the protein and result in altered enzyme kinetics.
  Journal
Hum Mutat 30:749-56 (2009)
DOI:10.1002/humu.20934
Reference
  Authors
Tabatabaie L, Klomp LW, Berger R, de Koning TJ
  Title
L-serine synthesis in the central nervous system: a review on serine deficiency disorders.
  Journal
Mol Genet Metab 99:256-62 (2010)
DOI:10.1016/j.ymgme.2009.10.012
LinkDB

» Japanese version

KEGG   DISEASE: Neu-Laxova syndrome
Entry
H02117                      Disease                                
Name
Neu-Laxova syndrome
Description
Neu-Laxova syndrome (NLS) is an autosomal recessive multiple malformation syndrome characterized by a recognizable pattern of severe malformations leading to prenatal or early postnatal lethality. It is characterized by ichthyosis, marked intrauterine growth restriction (IUGR), microcephaly, short neck, central nervous system anomalies, limb deformities, hypoplastic lungs, edema, and abnormal facial features. NLS is genetically heterogeneous and can be caused by mutations in the genes encoding enzymes of the L-serine biosynthesis pathway.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 20 Developmental anomalies
  Multiple developmental anomalies or syndromes
   LD20  Syndromes with central nervous system anomalies as a major feature
    H02117  Neu-Laxova syndrome
Pathway-based classification of diseases [BR:br08402]
 Amino acid metabolism
  nt06033  Glycine, serine and arginine metabolism
   H02117  Neu-Laxova syndrome
Pathway
hsa00260  Glycine, serine and threonine metabolism
hsa00750  Vitamin B6 metabolism
Network
nt06033 Glycine, serine and arginine metabolism
Gene
PHGDH [HSA:26227] [KO:K00058]
PSAT1 [HSA:29968] [KO:K00831]
Comment
See also H01079, H01082, and H02116.
Other DBs
ICD-11: LD20.1
MeSH: C536405
OMIM: 256520 616038
Reference
PMID:5547878
  Authors
Neu RL, Kajii T, Gardner LI, Nagyfy SF
  Title
A lethal syndrome of microcephaly with multiple congenital anomalies in three siblings.
  Journal
Pediatrics 47:610-2 (1971)
Reference
  Authors
Manning MA, Cunniff CM, Colby CE, El-Sayed YY, Hoyme HE
  Title
Neu-Laxova syndrome: detailed prenatal diagnostic and post-mortem findings and literature review.
  Journal
Am J Med Genet A 125A:240-9 (2004)
DOI:10.1002/ajmg.a.20467
Reference
  Authors
Shaheen R, Rahbeeni Z, Alhashem A, Faqeih E, Zhao Q, Xiong Y, Almoisheer A, Al-Qattan SM, Almadani HA, Al-Onazi N, Al-Baqawi BS, Saleh MA, Alkuraya FS
  Title
Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH.
  Journal
Am J Hum Genet 94:898-904 (2014)
DOI:10.1016/j.ajhg.2014.04.015
Reference
  Authors
Acuna-Hidalgo R, Schanze D, Kariminejad A, Nordgren A, Kariminejad MH, Conner P, Grigelioniene G, Nilsson D, Nordenskjold M, Wedell A, Freyer C, Wredenberg A, Wieczorek D, Gillessen-Kaesbach G, Kayserili H, Elcioglu N, Ghaderi-Sohi S, Goodarzi P, Setayesh H, van de Vorst M, Steehouwer M, Pfundt R, Krabichler B, Curry C, MacKenzie MG, Boycott KM, Gilissen C, Janecke AR, Hoischen A, Zenker M
  Title
Neu-Laxova syndrome is a heterogeneous metabolic disorder caused by defects in enzymes of the L-serine biosynthesis pathway.
  Journal
Am J Hum Genet 95:285-93 (2014)
DOI:10.1016/j.ajhg.2014.07.012
LinkDB

» Japanese version

DBGET integrated database retrieval system